A pilot study,review of the literature,and dosing guidelines for patient-controlled analgesia using subcutaneous morphine sulphate for chronic cancer pain

Abstract

Providing effective pain control without side effects is a major challenge in patients with advanced cancer. Oral analgesics may not be practical for a variety of reasons, and several alternatives for parenteral administration are available, including patient-controlled analgesia (PCA). This is a report of a pilot study of the effectiveness, dose requirements, side effects and practicality of continuous subcutaneous morphine infusion delivered by PCA in nine patients. A review of the literature of subcutaneous morphine infusions and guidelines for use are described. Continuous subcutaneous infusion of morphine via a PCA device appears to be a safe and effective method of pain control in patients with advanced cancer.

Keywords

analgesia infusion pumps morphine neoplasms patient participation percutaneous administration

Get full access to this article

View all access options for this article.

References

Walsh TD Cancer pain. In: Walsh TD ed. Symptom control. London: Blackwell , 1989:329-43.

Walsh TD Oral morphine in chronic cancer pain. Pain 1990; 18: 1-11.

Kerr IG , Sone M. , Deangelis C. , Iscoe N. , MacKenzie R. , Schueller T. Continuous narcotic infusion with PCA for chronic cancer pain in outpatients . Ann Intern Med 1988; 108: 554-57.

Bruera E. , Brenneis C. , Michaud M. et al. Use of subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer 1988; 62: 407-11.

Swanson G. , Smith J. , Bulich R. , New P. , Shiffman R. Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients. J Clin Oncol 1989 ; 7: 1903-1908.

Glare P. , Sheehan D. , Smyth E. , Walsh TD Pilot survey of the side effects of morphine sulphate in advanced cancer. [in preparation].

Walsh TD , Saunders CM Oral morphine for relief of chronic pain from cancer. N Engl J Med 1981; 305:1417.

Portenoy RK , Moulin DE , Rogers A. , Inturrisi CE , Foley KM Intravenous infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 1986; 70: 575-81.

Glare P. , Smyth E. , Walsh TD Continuous intravenous morphine sulphate infusions for cancer pain. [in preparation].

10.

Bonica JJ , Ekstrom JL Systemic opioids for the management of cancer pain: an updated review. In: Benedetti C , Chapman CR , Giron G eds. Opioid analgesia (Advances in pain research and therapy, volume 14). New York: Raven Press, 1990:425-46.

11.

Logan M. , Bourbonnais FF Continuous subcutaneous infusion of narcotics: an exploratory study of patient, family and nursing concerns. Hospice J 1990 ; 6: 69-77.

12.

Russell Psb. Analgesia in terminal malignant disease. Br Med J 1979; 1: 1561.

13.

Hutchinson H. , Leedham GD , Knight AM Continuous subcutaneous analgesics in domiciliary terminal care. Lancet 1981; ii: 1279.

14.

Campbell CF , Mason JB , Weiler JM Continuous subcutaneous infusion of morphine for the pain of terminal malignancy . Ann Intern Med 1983; 98: 51-52.

15.

Dickson RJ , Russell Psb. Continuous subcutaneous analgesics for terminal care at home. Lancet 1982; i: 165.

16.

Miser AW , Davis DM , Hughes CS , Mulne AF , Miser JS Continuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child 1983; 137: 383-85.

17.

Ventafridda V. , Spoldi E. , Carceni A. , Tamburini M De Conno F. The importance of continuous subcutaneous morphine administration for cancer pain control. Pain Clinic 1986; 1: 47-55.

18.

Coyle N. , Mauskop A. , Maggard J. , Foley KM Continuous subcutaneous infusions of opiates in cancer patients with pain . Oncol Nurs Forum 1986; 13: 53-57.

19.

Brenneis C. , Michaud M. , Bruera E. , MacDonald RN Local toxicity during the subcutaneous infusion of narcotics (SCIN). Cancer Nurs 1987; 10: 172-76.

20.

Benedetti C. Acute pain: a review of its effects and therapy with systemic opioids. In: Benedetti C , Chapman DR , Giron G eds. Opioid analgesia (Advances in pain research and therapy, volume 14). New York: Raven Press, 1990: 367-424.

21.

Citron ML , Johnston-Early A. , Boyer M. , Krasnow SH , Hood M. , Cohen MH Patient-controlled analgesia for severe cancer pain. Arch Intern Med 1986; 146: 734-36.

22.

Baumann TJ , Batenhorst RL , Graves DA , Foster TS , Bennett RL Patient-controlled analgesia in the terminally ill cancer patient. Drug Intell Clin Pharm 1986; 20: 297-301.

23.

Keeri-Szanto M. Demand analgesia for the relief of pain problems in 'terminal' illness. Anesth Rev 1976; 3: 19-21.

24.

Bruera E. , Brenneis C. , Michaud M. , MacMillan K. , Hanson J. , MacDonald RN Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. J Natl Cancer Inst 1988; 80: 1152-54.

25.

Drexel H. , Dzien A. , Spiegel RW et al. Treatment of severe cancer pain by low-dose continuous subcutaneous morphone. Pain 1989; 36: 169-76.

26.

Rutter PC , Murphy F. , Hadley Haf. Morphine: controlled trial of different methods of administration for post-operative pain relief. Br Med J 1980; 1: 12-13.